Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fosmanogepix by Basilea Pharmaceutica for Candidiasis: Likelihood of Approval
Fosmanogepix is under clinical development by Basilea Pharmaceutica and currently in Phase II for Candidiasis. According to GlobalData, Phase II...
Fosmanogepix by Basilea Pharmaceutica for Unspecified Fungal Infections: Likelihood of Approval
Fosmanogepix is under clinical development by Basilea Pharmaceutica and currently in Phase II for Unspecified Fungal Infections. According to GlobalData,...
Fosmanogepix by Basilea Pharmaceutica for Aspergillosis: Likelihood of Approval
Fosmanogepix is under clinical development by Basilea Pharmaceutica and currently in Phase II for Aspergillosis. According to GlobalData, Phase II...